The Uniphar (ISE:UPR) share price has done well in the last month, posting a gain of 31%. While recent buyers might be laughing, long term holders might not be so pleased, since the recent gain only ...

Uniphar is planning to integrate E4H, Devonshire Healthcare Services and Dublin-based Navi Group into its own operations. Dublin-headquartered healthcare services company Uniphar has announced three ...

Irish healthcare services firm Uniphar Group posted a nearly 10% increase in gross profit during 2024 as it reported strong growth in its pharma services and retail divisions. Among the companies ...

The CCPC found that Uniphar acquiring Navi would ‘substantially lessen competition’ in Ireland. Uniphar’s proposed acquisition of Irish pharma services group Navi has been blocked by Ireland’s ...

Rising interest rates and costs associated with the integration of newly acquired companies led to a decline in profits at Uniphar in the first half of the year despite a strong trading period for the ...

* UNIPHAR GROUP PLC - "IN LAST 20 DAYS, WE HAVE SEEN A SIGNIFICANT SPIKE IN DEMAND ACROSS ALL OF OUR THREE DIVISIONS" * UNIPHAR GROUP PLC - IN NEXT 12 WEEKS, EXPECT TO CONTINUE TO SEE INCREASED ...

This article first appeared on GuruFocus. Uniphar PLC (DUB:UPR) is set to release its Q2 2025 earnings on Sep 2, 2025. The consensus estimate for Q2 2025 revenue is 0, and the earnings are expected to ...

[Dublin, 9th October 2025] Uniphar, a global leader in pharmaceutical and medtech solutions, is making progress towards its near-term Science Based Targets initiative (SBTi) goal of halving Scope 1 ...

Healthcare services group Uniphar has reported higher revenues and profits for the year to the end of December and said it remains confident of achieving its target of €200m EBITDA by 2028. Uniphar ...

(Alliance News) - Uniphar on Tuesday reported increased revenue and pretax profit for 2025 as it said the trading momentum was "strong" and that such a performance represents a growth rate in line ...

Irish-listed healthcare group Uniphar has acquired Dutch pharmaceutical services business BModesto Group in a deal worth €75 million, including an upfront payment of €51 million. Chiefly focused on ...

Irish pharmaceuticals group Uniphar has completed its acquisition of Durbin, a specialist pharmaceuticals provider based in the UK and the US. Uniphar says Durbin will be integrated into its Product ...